Walter J. McConathy - Search Results

Year	Number of Results
1972	1
2002	4
2003	2
2005	2
2006	1
2007	2
2008	1
2010	1
2011	2
2012	1
2013	2
2015	1
2024	0

1

HDL as a drug and nucleic acid delivery vehicle.

Lacko AG, Sabnis NA, Nagarajan B, McConathy WJ. Lacko AG, et al. Among authors: mcconathy wj. Front Pharmacol. 2015 Oct 26;6:247. doi: 10.3389/fphar.2015.00247. eCollection 2015. Front Pharmacol. 2015. PMID: 26578957 Free PMC article. Review.

2

Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs.

Lacko AG, Nair M, Prokai L, McConathy WJ. Lacko AG, et al. Among authors: mcconathy wj. Expert Opin Drug Deliv. 2007 Nov;4(6):665-75. doi: 10.1517/17425247.4.6.665. Expert Opin Drug Deliv. 2007. PMID: 17970668 Review.

3

The role of cholesterol metabolism and cholesterol transport in carcinogenesis: a review of scientific findings, relevant to future cancer therapeutics.

Cruz PM, Mo H, McConathy WJ, Sabnis N, Lacko AG. Cruz PM, et al. Among authors: mcconathy wj. Front Pharmacol. 2013 Sep 25;4:119. doi: 10.3389/fphar.2013.00119. Front Pharmacol. 2013. PMID: 24093019 Free PMC article. Review.

4

Trojan horse meets magic bullet to spawn a novel, highly effective drug delivery model.

Lacko AG, Nair M, Paranjape S, Mooberry L, McConathy WJ. Lacko AG, et al. Among authors: mcconathy wj. Chemotherapy. 2006;52(4):171-3. doi: 10.1159/000093268. Epub 2006 May 10. Chemotherapy. 2006. PMID: 16691026 Review.

5

Recent developments and patenting of lipoprotein based formulations.

Lackó AG, Stewart DR, McClain R, Prókai L, McConathy WJ. Lackó AG, et al. Among authors: mcconathy wj. Recent Pat Drug Deliv Formul. 2007;1(2):143-5. doi: 10.2174/187221107780831914. Recent Pat Drug Deliv Formul. 2007. PMID: 19075881 Review.

6

Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles.

Shahzad MM, Mangala LS, Han HD, Lu C, Bottsford-Miller J, Nishimura M, Mora EM, Lee JW, Stone RL, Pecot CV, Thanapprapasr D, Roh JW, Gaur P, Nair MP, Park YY, Sabnis N, Deavers MT, Lee JS, Ellis LM, Lopez-Berestein G, McConathy WJ, Prokai L, Lacko AG, Sood AK. Shahzad MM, et al. Among authors: mcconathy wj. Neoplasia. 2011 Apr;13(4):309-19. doi: 10.1593/neo.101372. Neoplasia. 2011. PMID: 21472135 Free PMC article.

7

Evaluation of synthetic/reconstituted high-density lipoproteins as delivery vehicles for paclitaxel.

McConathy WJ, Nair MP, Paranjape S, Mooberry L, Lacko AG. McConathy WJ, et al. Anticancer Drugs. 2008 Feb;19(2):183-8. doi: 10.1097/CAD.0b013e3282f1da86. Anticancer Drugs. 2008. PMID: 18176115

8

Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier.

Mooberry LK, Nair M, Paranjape S, McConathy WJ, Lacko AG. Mooberry LK, et al. Among authors: mcconathy wj. J Drug Target. 2010 Jan;18(1):53-8. doi: 10.3109/10611860903156419. J Drug Target. 2010. PMID: 19637935

9

The potential role of nanotechnology in therapeutic approaches for triple negative breast cancer.

Johnson R, Sabnis N, McConathy WJ, Lacko AG. Johnson R, et al. Among authors: mcconathy wj. Pharmaceutics. 2013;5(2):353-70. doi: 10.3390/pharmaceutics5020353. Pharmaceutics. 2013. PMID: 24244833 Free PMC article.

10

Validation of the reconstituted high-density lipoprotein (rHDL) drug delivery platform using dilauryl fluorescein (DLF).

McConathy WJ, Paranjape S, Mooberry L, Buttreddy S, Nair M, Lacko AG. McConathy WJ, et al. Drug Deliv Transl Res. 2011 Apr;1(2):113-20. doi: 10.1007/s13346-010-0012-0. Drug Deliv Transl Res. 2011. PMID: 25788110

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

20 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Results by year